To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

PHASE2CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Type 2 Diabetes MellitusImpaired Glucose Tolerance
Interventions
DRUG

Canakinumab 150 mg

Single subcutaneous injection of Canakinumab 150 mg.

DRUG

Placebo to Canakinumab

Single subcutaneous injection of Placebo to Canakinumab.

Trial Locations (52)

Unknown

National Research Institute, Los Angeles

Crest Clinical Trials, Santa Ana

Encompass Clinical Research, Spring Valley

Commonwealth Biomedical Research LLC, Madisonville

University of Nebraska Medical Center, Omaha

VA Medical Center, Omaha

Lillestol Research LLC, Fargo

Preferred Primary Care Physicians, Pittsburgh

Dallas Diabetes and Endocrine Center, Dallas

Texas Center for Drug Development P.A., Houston

Utah Clinical Trials, Salt Lake City

Barwon Health - Geelong Hospital, Geelong

Austin Health - Heidelberg Repatriation Hospital, Heidelberg Heights

Melbourne Health - Royal Melbourne Hospital, Melbourne

Lifestyle Metabolism Centre (Etobicoke), Etobicoke

LMC Endocrinology Centres (Markham) Ltd, Markham

LMC Endocrinology Centres (Thornhill) Ltd, Thornhill

Centre de recherche clinique de Laval, Laval

Hôpital Maisonneuve-Rosemont, Montreal

Lihavuustutkimusyksikkö, Helsinki

Lääkärikeskus Mehiläinen Töölö, Helsinki

ODL Terveys Oy, Oulu

Clintrial Berlin Praxis fuer medizinische Studien, Berlin

Klinische Forschung Berlin-Buch Dr. Andrei Khariouzov, Berlin

Gemeinschaftspraxis Dr. Ingo Zeissig, Duisburg

"Sana Krankenhaus Gerresheim", Düsseldorf

Praxis Dr. Thorsten Rau, Essen

Praxis Dr. med. Joerg Luedemann, Falkensee

Dr. Helmut Anderten Gemeinschaftspraxis Dres. Anderten und Krok, Hildesheim

Praxis Dr. Julia Chevts, Karlsruhe

Pro Scientia Med, Lübeck

Praxis Dr. Winfried Keuthage, Münster

Praxis Dr. Uwe Boeckmann, Neumünster

Dr. Klaus Funke IkFE Studiencenter Potsdam GMBH I.G., Potsdam

Praxis Dr. Gerhard Steinmaier, Viernheim

Praxis Dr. Reinhold U. Schneider, Wetzlar-Naunheim

Visakha Diabetes & Endocrine Centre, Visakhapatnam

Jnana Sanjeevini Medical Center, Bangalore

Bangalore Diabetes Hospital,, Banglore

Health & Research Centre, Trivandrum

Diabetes Thyroid Hormone Research Institute Pvt .Ltd., Indore

Indrayani Speciality Hospital,, Nagpur

Sahyadri Hospital Bibewewadi Centre of Excellence for Diabetics, Pune

Madras Diabetes Research Foundation, Chennai

Azienda Ospedaliera-Ospedali Riuniti di BergamoU, Bergamo

Az. Ospedaliera Universit. S.Martino-Universita degli Studi, Genova

Azienda Ospedaliera S. Paolo-Polo Universitario, Milan

Fondazione Centro San Raffaele del Monte Tabor-IRCCSUnità, Milan

Az. Ospedaliera Della Prov.di Pavia, Casorate Primo

Policlinico A.Gemelli - Univ.Cattolica del Sacro Cuore, Roma

A.O.Universitaria Senese, Universita degli Studi di Siena, Siena

S.C.D.U. Endocrinologia e Malattie del Metabolismo, Torino

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY